Growth Metrics

BioNTech SE (BNTX) Cash & Current Investments (2018 - 2025)

BioNTech SE's Cash & Current Investments history spans 8 years, with the latest figure at $20.1 billion for Q4 2025.

  • On a quarterly basis, Cash & Current Investments rose 12.25% to $20.1 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $20.1 billion, a 12.25% increase, with the full-year FY2025 number at $19.5 billion, up 8.95% from a year prior.
  • Cash & Current Investments hit $20.1 billion in Q4 2025 for BioNTech SE, up from $17.0 billion in the prior quarter.
  • Over the last five years, Cash & Current Investments for BNTX hit a ceiling of $1459786.9 billion in Q1 2021 and a floor of $1.4 billion in Q3 2021.
  • Historically, Cash & Current Investments has averaged $73096.8 billion across 5 years, with a median of $16.8 billion in 2023.
  • The widest YoY moves for Cash & Current Investments: up 563.22% in 2022, down 99.87% in 2022.
  • Tracing BNTX's Cash & Current Investments over 5 years: stood at $2.4 billion in 2021, then surged by 504.7% to $14.3 billion in 2022, then grew by 24.09% to $17.8 billion in 2023, then grew by 0.73% to $17.9 billion in 2024, then grew by 12.25% to $20.1 billion in 2025.
  • Business Quant data shows Cash & Current Investments for BNTX at $20.1 billion in Q4 2025, $17.0 billion in Q3 2025, and $15.8 billion in Q2 2025.